Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03

G. D'Addario; D. Rauch; R. Stupp; M. Pless; R. Stahel; N. Mach; L. Jost; L. Widmer; C. Tapia; M. Bihl; M. Mayer; K. Ribi; S. Lerch; L. Bubendorf; D.C. Betticher

doi:10.1093/annonc/mdm564

Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03

G. D'Addario
, D. Rauch
, R. Stupp
, M. Pless
, R. Stahel
, N. Mach
, L. Jost
, L. Widmer
, C. Tapia
, M. Bihl
, M. Mayer
, K. Ribi
, S. Lerch
, L. Bubendorf
, D.C. Betticher

Careum Hochschule Gesundheit

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	739-745
Fachzeitschrift	Annals of Oncology
Jahrgang	19
Ausgabenummer	4
DOIs	https://doi.org/10.1093/annonc/mdm564
Publikationsstatus	Veröffentlicht - 1 Apr. 2008

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Zugriff auf Dokument

10.1093/annonc/mdm564Lizenz: Sonstige

https://linkinghub.elsevier.com/retrieve/pii/S0923753419414580

Dieses zitieren

D'Addario, G., Rauch, D., Stupp, R., Pless, M., Stahel, R., Mach, N., Jost, L., Widmer, L., Tapia, C., Bihl, M., Mayer, M., Ribi, K., Lerch, S., Bubendorf, L., & Betticher, D. C. (2008). Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03. Annals of Oncology, 19(4), 739-745. https://doi.org/10.1093/annonc/mdm564

@article{bf7d5239eefc412ca78e82dc9c241cbb,

title = "Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03",

author = "G. D'Addario and D. Rauch and R. Stupp and M. Pless and R. Stahel and N. Mach and L. Jost and L. Widmer and C. Tapia and M. Bihl and M. Mayer and K. Ribi and S. Lerch and L. Bubendorf and D.C. Betticher",

year = "2008",

month = apr,

day = "1",

doi = "10.1093/annonc/mdm564",

language = "English",

volume = "19",

pages = "739--745",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "4",

}

D'Addario, G, Rauch, D, Stupp, R, Pless, M, Stahel, R, Mach, N, Jost, L, Widmer, L, Tapia, C, Bihl, M, Mayer, M, Ribi, K, Lerch, S, Bubendorf, L & Betticher, DC 2008, 'Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03', Annals of Oncology, Jg. 19, Nr. 4, S. 739-745. https://doi.org/10.1093/annonc/mdm564

TY - JOUR

T1 - Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03

AU - D'Addario, G.

AU - Rauch, D.

AU - Stupp, R.

AU - Pless, M.

AU - Stahel, R.

AU - Mach, N.

AU - Jost, L.

AU - Widmer, L.

AU - Tapia, C.

AU - Bihl, M.

AU - Mayer, M.

AU - Ribi, K.

AU - Lerch, S.

AU - Bubendorf, L.

AU - Betticher, D.C.

PY - 2008/4/1

Y1 - 2008/4/1

U2 - 10.1093/annonc/mdm564

DO - 10.1093/annonc/mdm564

M3 - Article

SN - 0923-7534

VL - 19

SP - 739

EP - 745

JO - Annals of Oncology

JF - Annals of Oncology

IS - 4

ER -